Researchers at the University of California, San Francisco have uncovered drastic differences between the gut bacteria profiles of patients with multiple sclerosis (MS) and their healthy counterparts.
The study showed that gut microbiome was associated with multiple sclerosis risk and disease stage.
The findings uncovered distinct microbe-microbe interactions among the multiple sclerosis patients.
“We observed a significantly increased proportion of Akkermansia muciniphila, Ruthenibacterium lactatiformans, Hungatella hathewayi, and Eisenbergiella tayi and decreased Faecalibacterium prausnitzii and Blautia species,” according to the findings from the report in Cell.
“Distinct microbial networks were observed in untreated MS and healthy controls.”
“These results strongly support specific gut microbiome associations with MS risk, course and progression, and functional changes in response to treatment.”
